Implication of oxidative stress in progression of diabetic retinopathy

Survey of Ophthalmology

Volumn 61, Issue 2, 2016, Pages 187-196

  Behl, Tapan ^a   Kaur, Ishneet ^b   Kotwani, Anita ^a  

^a UNIVERSITY OF DELHI   (India)

^b Chandigarh College of Pharmacy   (India)

Author keywords

AGEs (advanced glycation end products); Polyol pathway; Protein kinase C; ROS (reactive oxygen species); Superoxide radical

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE; CYTOCHROME C; FREE RADICAL; GLUCOSE; POLYOL; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; VISUAL PIGMENT; ADVANCED GLYCATION END PRODUCT; POLYMER; SUPEROXIDE;

APOPTOSIS; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; DISEASE COURSE; METABOLISM;

ANIMALS; DIABETIC RETINOPATHY; DISEASE PROGRESSION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; OXIDATIVE STRESS; POLYMERS; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 84959241807     PISSN: 00396257     EISSN: 18793304     Source Type: Journal    
DOI: 10.1016/j.survophthal.2015.06.001     Document Type: Review

References (64)

1. Baba S.P., Barski O.A., Ahmed Y., et al. Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue. Diabetes 2009, 58(11):2486-2497.
2. Beatty S., van Kuijk F.J.G.M., Chakravarthy U. Macular pigment and age-related macular degeneration: longitudinal data and better techniques of measurement are needed. Invest Ophthalmol Vis Sci 2008, 49(3):843-845.
3. Behl T., Kaur I., Goel H., Pandey R.K. Diabetic nephropathy and diabetic retinopathy as major health burdens in modern era. World Journal of Pharmacy and Pharmaceutical Sciences 2014, 3(7):370-387.
4. Behl T., Kaur I., Goel H., Pandey R.K. PKC activation in the pathogenesis of various diabetic complications. Asian Journal of Biochemical and Pharmaceutical Research 2014, 2(4):232-245.
5. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
6. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54(6):1615-1625.
7. Brune B. Nitric oxide: NO apoptosis or turning it ON?. Cell Death Differ 2003, 10(8):864-869.
8. Cai J., Nelson K.C., Wu K., Sternberg S., Jones D.P. Oxidative damage and protection of the RPE. Prog Retin Eye Res 2000, 19(2):205-221.
9. Cande C., Cecconi F., Dessen P., Kroemer G. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death?. J Cell Sci 2002, 115(Pt 24):4727-4734.
10. Cecconi F., Roth K.A., Dolgov O., et al. Apaf1-dependent programmed cell death is required for inner ear morphogenesis and growth. Development 2004, 131(9):2125-2135.
11. Chow A., Foster H., Gonzalez V., Mclver L. The disparate impact of diabetes on racial/ethnic minority populations. Clinical Diabetes 2012, 30(3):130-133.
12. Chung S.S., Ho E.C., Lam K.S., Chung S.K. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 2003, 14(8 Suppl 3):S233-S236.
13. Comer G.M., Ciulla T.A. Pharmacotherapy for diabetic retinopathy. Curr Opin Ophthalmol 2004, 15(6):508-518.
14. Cutler R.G. Oxidative stress profiling-part I. Its potential importance in the optimization of human health. Ann N Y Acad Sci 2005, 1055:93-135.
15. Dizdaroglu M., Jaruga P., Birincioglu M., Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med 2002, 32(11):1102-1115.
16. El-Beltagi H.S., Mohamed H.I. Reactive oxygen species, lipid peroxidation and antioxidative defense mechanism. Not Bot Horti Agrobo 2013, 41(1):44-57.
17. Fan T.J., Xia L., Han Y.R. Mitochondrion and apoptosis. Acta Biochim Biophys Sin 2001, 33(1):7-12.
18. Fan T.J., Han L.H., Cong R.S., Liang J. Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai) 2005, 37(11):719-727.
19. Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010, 107(9):1058-1070.
20. Gogvadze V., Orrenius S., Zhivotovsky B. Multiple pathways of cytochrome C release from mitochondria in apoptosis. Biochim Biophys Acta 2006, 1757(5-6):639-647.
21. Halliwell B. Free radicals and antioxidants-quo vadis?. Trends Pharmacol Sci 2011, 32(3):125-130.
22. Higdon J.V., Frei B. Obesity and oxidative stress: a direct link to CVD?. Arterioscler Thromb Vasc Biol 2003, 23(3):365-367.
23. Hoesel B., Schmid J.A. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer 2013, 12:86.
24. Ishida S., Usui T., Yamashiro K., et al. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med 2003, 198(3):483-489.
25. Jingi A.M., Noubiap J.J.N., Ellong A., Bigna J.J.R., Mvogo C.E. Epidemiology and treatment outcomes of diabetic retinopathy in a diabetic population from Cameroon. BMC Ophthalmol 2014, 14:19.
26. Joussen A.M., Murata T., Tsujikawa A., et al. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 2001, 158(1):147-152.
27. Joussen A.M., Poulaki V., Le M.L., et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004, 18(12):1450-1452.
28. Kowluru R.A. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 2003, 52:818-823.
29. Kowluru R.A., Chan P.S. Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007, 2007:43603.
30. Lassègue B., Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003, 285(2):R277-R297.
31. Lobo V., Patil A., Phatak A., Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev 2010, 4(8):118-126.
32. Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res 2007, 2007:61038.
33. Marin P., Maus M., Bockaert J., Glowinski J., Prémont J. Oxygen free radicals enhance the nitric oxide-induced covalent NAD(+)-linkage to neuronal glyceraldehyde-3-phosphate dehydrogenase. Biochem J 1995, 309(Pt 3):891-898.
34. Martyn J.A.J., Kaneki M., Yasuhara S. Obesity-induced insulin resistance and hyperglycemia: etiological factors and molecular mechanisms. Anesthesiology 2008, 109(1):137-148.
35. Monnier P.P., D'Onofrio P.M., Magharious M., et al. Involvement of caspase-6 and caspase-8 in neuronal apoptosis and the regenerative failure of injured retinal ganglion cells. J Neurosci 2011, 31(29):10494-10505.
36. Mullard A. Mechanisms of disease: kinases out of control-brake line cut!. Mol Cell Biol 2007, 8(11):854.
37. Muller F.L., Lustgarten M.S., Jang Y., Richardson A., Van Remmen H. Trends in oxidative aging theories. Free Radic Biol Med 2007, 43(4):477-503.
38. Nigishi H. Is there a place for inhibition of transforming growth factor-β and the polyol pathway in therapy for diabetic retinopathy?. J Diabetes Investig 2010, 1(4):134-136.
39. Nowak J.Z. Oxidative stress, polyunsaturated fatty acids-derived oxidation products and bisretinoids as potential inducers of CNS diseases: focus on age-related macular degeneration. Pharmacol Rep 2013, 65(2):288-304.
40. Oates P.J. The polyol pathway and diabetic peripheral neuropathy. Neurobiology of Diabetic Neuropathy 2002, 325-392. Academic Press, London, UK. D.R. Tomlinson (Ed.).
41. Obrosova I.G., Minchenko A.G., Vasupuram R., et al. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes 2003, 52(3):864-871.
42. Punzo C., Xiong W., Cepko C.L. Loss of daylight vision in retinal degeneration: are oxidative stress and metabolic dysregulation to blame?. J Biol Chem 2012, 287(3):1642-1648.
43. Quan N., He L., Lai W. Endothelial activation is an intermediate step for peripheral lipopolysaccharide induced activation of paraventricular nucleus. Brain Res Bull 2003, 59:447-452.
44. Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2007, 2(2):219-236.
45. Ramana K.V., Friedrich B., Srivastava S., Bhatnagar A., Srivastava S.K. Activation of nulcear factor-κB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes 2004, 53(11):2910-2920.
46. Rotstein N.P., Politi L.E., German O.L., Girotti R. Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest Ophthalmol Vis Sci 2003, 44(5):2252-2259.
47. Safi S.Z., Qvist R., Kumar S., Batumalaie K., Ismail I.S. Molecular mechanisms of diabetic retinopathy, general preventive strategies and novel therapeutic targets. Biomed Res Int 2014, 2014:801269.
48. Salvi A., Carrupt P.A., Tillement J.P., Testa B. Structural damage to proteins caused by free radicals: assessment, protection by antioxidants, and influence of protein binding. Biochem Pharmacol 2001, 61(10):1237-1242.
49. SanGiovanni J.P., Chew E.Y. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 2005, 24(1):87-138.
50. Schoenberger S.D., Kim S.J., Sheng J., et al. Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines. Invest Ophthalmol Vis Sci 2012, 53(9):5906-5911.
51. Suzen S., Buyukbingol E. Recent studies of aldose reductase enzyme inhibition for diabetic complications. Curr Med Chem 2003, 10(15):1329-1352.
52. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2(6):442-454.
53. Vistoli G., de Maddis D., Cipak A., et al. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res 2013, 47(S1):3-27.
54. Wilkinson C.P., Ferris F.L., Klein R.E., et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110(9):1677-1682.
55. Wilkinson-Berka J.L. Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide. Curr Pharm Des 2004, 10(27):3331-3348.
56. Xu H., Czerwinski P., Hortman M., et al. Protein kinase C-alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor. Cardiovasc Res 2008, 78:349-355.
57. Xue J., Ray R., Singer D., et al. The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs. Biochemistry 2014, 53(20):3327-3335.
58. Yao D., Brownlee M. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 2010, 59(1):249-255.
59. Yeh C.C., Chang H.I., Chiang J.K., et al. Regulation of plasminogen activator inhibitor 1 expression in human osteoarthritic chondrocytes by fluid shear stress: role of protein kinase C alpha. Arthritis Rheum 2009, 60(8):2350-2361.
60. Yigong S. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2012, 9(3):459-470.
61. Young T.A., Cunningham C.C., Bailey S.M. Reactive oxygen species production by the mitochondrial respiratory chain in isolated rat hepatocytes and liver mitochondria: studies using myxothiazol. Arch Biochem Biophys 2002, 405(1):65-72.
62. Yuuki T., Kanda T., Kimura Y., et al. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications 2001, 15(5):257-259.
63. Zhang X., Saaddine J.B., Klein R. Prevalence of diabetic retinopathy in the Unites States, 2005-2008. JAMA 2010, 304(6):649-656.
64. Zong H., Ward M., Madden A., et al. Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE). Diabetologia 2010, 53(12):2656-2666.